​Dell EMC has announced its new high performance computing (HPC) cloud offerings, software, systems and customer success, continuing its focus on democratizing HPC for enterprises of all sizes, optimizing HPC technology innovations and advancing the HPC community.

“The global HPC market forecast exceeds $30 billion in 2016 for all product and services spending, including servers, software, storage, cloud, and other categories, with continued growth expected at 5.2 percent CAGR through 2020,” saidAddison Snell, CEO, Intersect360 Research. “Bolstered by its combination with EMC, Dell will hold the number-one position in total HPC revenue share heading into 2017.”

“In recent years, High Performance Computing has enabled for breakthrough innovation in the field of life sciences, healthcare, R&D across various verticals, and has also accelerated progress in India’s national supercomputing mission,”said Manish Gupta, Director & General Manager, Infrastructure Solutions Group, Dell India. “We strongly believe that our customers in India will be able to further accelerate the progress of technology development in their respective domains by deploying our expanded line of High Performance Computing solutions that are developed to provide performance, productivity, efficiency, flexibility and a significantly reduced time to deploy.”

·The Dell EMC HPC System for Life Sciences will be available with the PowerEdge C6320p Server with the Intel Xeon Phi processor by early Q1 2017. This accelerates results for bioinformatics centers to identify treatments in clinically relevant timeframes while protecting confidential data.

·New cloud bursting services from Cycle Computing, enabling cloud orchestration and management, connecting to the three largest public cloud services including Azure, AWS and Google. This allows customers of all sizes to most efficiently utilize their on-premises systems while seamlessly providing access to the vast resources of the public cloud for HPC needs.

·Dell EMC will offer customers the Intel HPC Orchestrator this quarter to help simplify the installation, management and ongoing maintenance of high-performance computing systems. Intel HPC Orchestrator, based on the OpenHPC open source project, can help accelerate customers’ time to results and value in their HPC deployments.

Optimizing HPC Portfolio for Performance and Efficiency

Dell EMC, as the global leader in server shipments, enterprise storage and converged systems, offers a robust portfolio optimized for HPC, available all in one place. New examples of innovative HPC technology being demonstrated at SC16 this week include:

·Dell EMC PowerEdge C4130 and R730 servers are now available with NVIDIA Tesla P100 accelerators, designed to boost throughput and save money for HPC and hyperscale data centers, advancing intensivedeep learning applications and applying artificial intelligence techniques to drive advances in science.

·The University of Pisa is using the Dell EMC PowerEdge C4130 servers, with NVIDIA Tesla P100 accelerators and NVIDIA Deep Learning GPU Training System (DIGITS), for deep learning of DNA sequencing.

MIT Lincoln Laboratory Supercomputing Center (LLSC)has selected Dell EMC to install a 648-node HPC system through the Dell EMC and Intel early access program for the Intel Xeon Phi processor. LLSC’s new “TX-Green” system, one of the largest of its kind on the US East Coast, exceeds one petaflop and has provided the center with a 4X computing capacity boost.

The new HPC system provides the LLSC’s researchers and collaborators a dramatic increase in its interactive, on-demand HPC and big data capabilities to enable research in fields such as space observations, robotic vehicles, cyber security, machine learning, sensor processing, electronic devices, bioinformatics, and air traffic control.

Peking University has selected Dell EMC to install two HPC clusters to further cryo-electron microscopy (cryo-EM) cooperative research with Harvard University. These clusters, with 144 nodes and approximately two petabytes of storage with Intel EE Lustre, will enable university researchers to map the three-dimensional structure of biological macromolecules to design inhibitors and develop new drugs to treat or cure patients of cancer and other diseases.